Cefiderocol
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Patients ≥18 y/o for the treatment of the following infections caused by susceptible Gram-negative microorganisms:
- Complicated urinary tract infections (cUTI), including pyelonephritis
- Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP)
NON-FDA APPROVED USES
- MDR GNR (e.g. Pseudomonas, Acinetobacter, CRO) infections when no other alternatives are available
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Patients ≥18 y/o for the treatment of the following infections caused by susceptible Gram-negative microorganisms:
- Complicated urinary tract infections (cUTI), including pyelonephritis
- Hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP)
NON-FDA APPROVED USES
- MDR GNR (e.g. Pseudomonas, Acinetobacter, CRO) infections when no other alternatives are available
There's more to see -- the rest of this entry is available only to subscribers.